Alaunos Therapeutics, Inc..
TCRT.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Alaunos Therapeutics, Inc. is a clinical-stage T-cell receptor (TCR) therapy company focused on developing transformative, personalized adoptive T-cell therapies for solid tumors. The company engineers T-cells to target specific cancer antigens, aiming to provide durable responses for patients with ...Show More
Better Health for All
0
No evidence available to assess Alaunos Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Alaunos Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
-40
The company experienced a significant workforce reduction in 2023, with 95% of its workforce reduced due to restructuring.
1
This indicates a very high turnover rate.
Fair Trade & Ethical Sourcing
0
No specific, concrete data points were found in the provided articles to assess Alaunos Therapeutics, Inc. against any of the Fair Trade & Ethical Sourcing KPIs, including fair trade certification share, audit frequency, forced or child labor incidents, traceability coverage, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend.
1
The articles explicitly state that no such data is present or applicable for these metrics.
2
Honest & Fair Business
0
No specific, concrete evidence relevant to the 'Honest & Fair Business' ethical value for Alaunos Therapeutics (TCRT.US) was found in the provided articles. The articles discuss general financial results and market research for an unrelated industry, without offering data points for regulatory fines, transparency, policies, financial restatements, audit coverage, ESG controversies, complaint resolution, board conflicts, anti-corruption measures, or third-party verification.
1
Kind to Animals
-60
Alaunos Therapeutics, Inc. conducts preclinical studies on animals to evaluate the safety and efficacy of its product candidates, including a planned proof-of-concept diet-induced obesity mouse study by the third quarter of 2025.
1
The company explicitly states that preclinical laboratory tests and animal studies are conducted according to Good Laboratory Practices (GLPs) and applicable requirements for the humane use of laboratory animals.
2
While the company uses in vitro testing for some drug candidates, such as darinaparsin and ALN1001, and for early-stage studies, it also relies on in vivo animal studies for safety and efficacy assessments.
3
There is no evidence of a formal policy to reduce or phase out animal testing, nor are specific animal testing volumes disclosed.
4
The company's continued reliance on animal studies for drug development, including a planned mouse study, indicates that animal testing is a standard and significant part of its operations.
No War, No Weapons
0
No specific, concrete data points were found in the provided articles to assess Alaunos Therapeutics, Inc. against the 'No War, No Weapons' ethical value.
1
The articles either discuss general export control regulations without mentioning the company or explicitly state that sustainability data for TCRT.US is unavailable.
Planet-Friendly Business
0
No specific, quantitative data points for any of the Planet-Friendly Business KPIs were found in the provided articles.
1
The articles explicitly state that sustainability data or quantitative information relevant to the requested metrics is unavailable for Alaunos Therapeutics, Inc.
2
Respect for Cultures & Communities
0
No relevant data regarding TCRT.US's respect for cultures and communities was found in the provided article.
1
The article explicitly states that no data could be extracted for TCRT.US, therefore no KPIs can be scored.
2
Safe & Smart Tech
0
No evidence available to assess Alaunos Therapeutics, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, quantitative evidence regarding TCRT.US's performance on waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education was found in the provided articles.
1